...
首页> 外文期刊>Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences >Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: Evidence from transcranial magnetic stimulation.
【24h】

Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: Evidence from transcranial magnetic stimulation.

机译:帕金森氏病中保留了与时限相关的可塑性,并且通过多巴胺得以增强:经颅磁刺激的证据。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We sought to investigate the effects of dopamine on motor cortical plasticity in Parkinson's disease (PD) using a novel interventional transcranial magnetic stimulation protocol that targets spike-timing-dependent plasticity (iTMS). Six patients (3F, mean age 62 years) with mild-moderate PD (mean disease duration 6 years, UPDRS-off 13, UPDRS-on 3, H&Y stage 2, daily levodopa dosage 450mg) were studied off and on levodopa on separate days. Paired TMS pulses at resting motor threshold with an inter-stimulus interval of 1.5ms were given over the hand area of the motor cortex for 20min at 0.2Hz. Single-pulse motor evoked potential (MEP) amplitude and visually cued simple reaction time (SRT) were measured before and after iTMS. When on levodopa, MEP amplitude increased to 278+/-36% of baseline (p<0.01), and when off levodopa to 157+/-13% of baseline (p=0.02). All patients showed a significantly greater increase in MEP amplitude when on levodopa than off levodopa (p=0.01). SRT was reduced to 95% baseline after iTMS off levodopa (p=0.02), but did not change on levodopa. These findings indicate that motor cortex plasticity to iTMS is preserved in mild-moderate PD. The effects of this spike-timing-related TMS protocol on cortical excitability were consistent and were enhanced by levodopa. The results support the important role of dopamine in regulating synaptic plasticity and justify a larger crossover study to assess the therapeutic effects of iTMS in PD.
机译:我们试图研究一种新型的经皮颅磁刺激性介入方案,以多巴胺定时依赖性可塑性(iTMS)为目标,研究多巴胺对帕金森氏病(PD)中运动皮质可塑性的影响。分别对6例轻度中度PD(平均病程6年,UPDRS-off 13,UPDRS-on 3,H&Y 2期,平均左旋多巴剂量450mg)的患者(左旋多巴,每天停用左旋多巴)进行研究。 。在运动皮层的手部区域以0.2Hz的频率在静止的运动阈值处以配对的TMS脉冲间隔1.5ms刺激20分钟。在iTMS之前和之后测量单脉冲电动机诱发电位(MEP)幅度和视觉提示的简单反应时间(SRT)。在左旋多巴上时,MEP振幅增加到基线的278 +/- 36%(p <0.01),当离开左旋多巴时,MEP振幅增加到基线的157 +/- 13%(p = 0.02)。所有患者在左旋多巴时均显示MEP振幅明显高于左旋多巴时(P = 0.01)。 iTMS停用左旋多巴后,SRT降至基线的95%(p = 0.02),但左旋多巴不变。这些发现表明,在中度-中度PD中保留了运动皮层对iTMS的可塑性。这种与穗定时相关的TMS协议对皮层兴奋性的影响是一致的,左旋多巴可增强这种影响。这些结果支持了多巴胺在调节突触可塑性中的重要作用,并证明了一项更大的交叉研究来评估iTMS在PD中的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号